Search Results - kathryn+wagner

1 Results Sort By:
Human IPSC-Based Drug Testing Platform for Duchenne Muscular Dystrophy
Unmet NeedThe development of new drugs is a capital and time intensive process. For this reason, the development of orphan drugs for those diseases that affect a small subset of the population. One of such diseases, Duchenne’s muscular dystrophy (DMD) affects 1 in 5000 boys worldwide and has no known cure. Current drug screen platforms include animal...
Published: 9/27/2024   |   Inventor(s): Gabsang Lee, Kathryn Wagner, Congshan (Sunny) Sun
Keywords(s): Discovery/Research Tools, Disease Indication, In Vitro Research Tool, Muscular Disorders, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Research Tools > Research Stem Cells
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum